Our proprietary services are based on the expertise and research of our scientific founder, Dr. Mary Jane Cunningham.  While she has over 25 years experience, she has been a leader in applying gene and protein expression profiling to efficacy and safety assessment for the past 15 years.  Dr. Cunningham is also one of the first investigators in nanotoxicology with 6 years experience in working with nanomaterials.